NCT04751448Completed
COLON-MD: Colon Cancer Longitudinal Study
COLON MD: Colon Cancer Longitudinal Study of the Microbial Metabolites and Dietary Factors That Influence Response to Treatment
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 11 (actual)
- First submitted
- 2 Feb 2021
- Start date
- 1 Feb 2021
- Primary completion date
- 15 May 2026
- Lead sponsor
- Baylor Research Institute
- Diseases
- Colorectal cancer
- NCT number
- NCT04751448
What you commit to
- Study type: Observational
- Participants enrolled: 11
- From 1 Feb 2021 to the primary completion date, 15 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- history of prior colon cancer diagnosis
- previous treatment with antibiotics in the last month.
- previous bowel resection.
Other illness
- Does not have Lynch syndrome or FAP diagnosis.
Other
- Not Pregnant
- Inability to perform inform consent
- inability to comply with follow up program
Who the study is looking for
- Colon cancer diagnosis
- Age \>18 and \< or equal to 79.
- Ability to perform informed consent
- FOLFOX treatment expected
Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor Research Institute Coordinator of this site? Confirm its status | Temple | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.